---
$id: https://graph.org.ai/products/commodity/51171968
$type: Product
source: UNSPSC
code: "51171968"
title: "Tiquinamide"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tiquinamide

**UNSPSC Code**: 51171968
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C11H14N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51O951X8V9, chemically known as 5,6,7,8-tetrahydro-3-methyl-8-quinolinecarbothioamide but generally known as tiquinamide, which bears US NIH Compound Identifier 3003921. European Medicines Agency schedules Tiquinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11112MIG. The term TIQUINAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). TIQUINAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiquinamide under HS 29334990 and SITC 51575. As of Q4 2014, TIQUINAMIDE remains the US FDA Preferred Term for this commodity. Tiquinamide bears US NLM identifiers UMLS ID C0076720 and NCI Concept Code C90778. SMILES: CC1=CN=C2C(CCCC2=C1)C(=S)N.

